Check out this morning's top movers from around Wall Street, compiled by The Fly. 

HIGHER -

• Xeris Pharmaceuticals (XERS) up 22% after announcing that the European Commission has approved Ogluo injection for the treatment of severe hypoglycaemia in adults, adolescents and children aged two years and over with diabetes mellitus
• NantKwest (NK) up 10% after announcing that they have received FDA authorization to expand Phase I testing of a bivalent hAd5 T-cell COVID-19 vaccine
• Fusion Acquisition (FUSE) up 5% after MoneyLion and the company have entered into a definitive agreement which would result in MoneyLion becoming a publicly listed company
• Inovio Pharmaceuticals (INO) up 20% after Oppenheimer analyst Hartaj Singh initiated coverage of shares with an Outperform rating and $35 price target

UP AFTER EARNINGS -

• Disney (DIS) up 1%
• HubSpot (HUBS) up 19%

DOWN AFTER EARNINGS -

• Newell Brands (NWL) down 4%
• Limelight Networks (LLNW) down 23%

LOWER -

• Virgin Galactic (SPCE) down 10% after stating in a tweet that the company has decided to allow more time for technical checks before a flight test
• Protalix (PLX) down 17% after 7.6M share spot secondary priced at $4.60
• Codiak (CDAK) down 9% after 2.75M share secondary priced at $21.00
• SOS Limited (SOS) down 14% after raising $110M in a registered direct offering